ATE198274T1 - 17 beta-aryl-4-aza-steroidderivate - Google Patents
17 beta-aryl-4-aza-steroidderivateInfo
- Publication number
- ATE198274T1 ATE198274T1 AT95916443T AT95916443T ATE198274T1 AT E198274 T1 ATE198274 T1 AT E198274T1 AT 95916443 T AT95916443 T AT 95916443T AT 95916443 T AT95916443 T AT 95916443T AT E198274 T1 ATE198274 T1 AT E198274T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- aryl
- steroid derivatives
- aza steroid
- aza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/230,277 US5525608A (en) | 1994-04-20 | 1994-04-20 | 17b-aryl-4-aza-steroid derivatives useful as 5-alpha-reductase inhibitors |
PCT/US1995/004743 WO1995028928A1 (en) | 1994-04-20 | 1995-04-17 | 17β-ARYL-4-AZA-STEROID DERIVATIVES |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE198274T1 true ATE198274T1 (de) | 2001-01-15 |
Family
ID=22864586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95916443T ATE198274T1 (de) | 1994-04-20 | 1995-04-17 | 17 beta-aryl-4-aza-steroidderivate |
Country Status (8)
Country | Link |
---|---|
US (1) | US5525608A (de) |
EP (1) | EP0756481B1 (de) |
JP (1) | JPH09512535A (de) |
AT (1) | ATE198274T1 (de) |
AU (1) | AU684634B2 (de) |
CA (1) | CA2188034A1 (de) |
DE (1) | DE69519728D1 (de) |
WO (1) | WO1995028928A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW382595B (en) * | 1993-10-15 | 2000-02-21 | Merck & Co Inc | Pharmaceutical composition for use in arresting and reversing androgenic alopecia |
US5547957A (en) * | 1993-10-15 | 1996-08-20 | Merck & Co., Inc. | Method of treating androgenic alopecia with 5-α reductase inhibitors |
ATE175420T1 (de) * | 1993-10-21 | 1999-01-15 | Merck & Co Inc | 16-substituierte-4-aza-androstan-5-alpha- reduktase-isozym-i-inhibitoren |
US5470976A (en) * | 1994-09-07 | 1995-11-28 | Merck & Co., Inc. | Process for the stereoselective reduction of steroid enelactams |
US5872126A (en) * | 1996-09-06 | 1999-02-16 | Merck & Co., Inc. | Methods and compositions for treating preterm labor |
US5935968A (en) | 1997-03-17 | 1999-08-10 | Merck & Co., Inc. | Methods for treating polycystic ovary syndrome |
CA2283098A1 (en) * | 1997-03-17 | 1998-09-24 | Merck & Co., Inc. | Methods and compositions for treating polycystic ovary syndrome |
CN1849120A (zh) * | 2003-09-10 | 2006-10-18 | 默克公司 | 作为雄激素受体调节剂的17-杂环-4-氮杂甾类衍生物 |
CN1849126A (zh) * | 2003-09-10 | 2006-10-18 | 默克公司 | 作为雄激素受体调节剂的17-杂环-4-氮杂甾族衍生物 |
EP1696925A4 (de) * | 2003-10-31 | 2009-11-18 | Merck & Co Inc | 21-heterocyclische 4-azasteroid-derivate als androgen-rezeptor-modulatoren |
BRPI0920681A2 (pt) * | 2008-10-28 | 2015-12-29 | Biomarin Pharm Inc | inibidores de decahidro-1h-indenoquinolinona e decahidro-3h-ciclopentafenantridinona de cyp17 |
WO2023070071A2 (en) * | 2021-10-21 | 2023-04-27 | The Board Of Trustees Of The University Of Illinois | Small molecule activators of the immune system |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4377584A (en) * | 1978-04-13 | 1983-03-22 | Merck & Co., Inc. | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors |
US5049562A (en) * | 1984-02-27 | 1991-09-17 | Merck & Co., Inc. | 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors |
US4760071A (en) * | 1984-02-27 | 1988-07-26 | Merck & Co., Inc. | 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors |
US4882319A (en) * | 1988-12-23 | 1989-11-21 | Smithkline Beckman Corporation | Phosphonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase |
US5098908A (en) * | 1990-06-20 | 1992-03-24 | Merck & Co., Inc. | 17β-hydroxybenzoyl-4-aza-5α-androst-1-en-3-ones as testosterone reductase inhibitors |
US5162332A (en) * | 1990-06-20 | 1992-11-10 | Merck & Co., Inc. | Selected 17 β-polyaroyl-4-aza-5 α-androst-1-en-3-ones as steroidal reductase inhibitors |
US5151430A (en) * | 1990-06-20 | 1992-09-29 | Merck & Co., Inc. | Specific 17β-thiobenzoyl-4-aza-5α-androst-1-en-3-ones as antiandrogen agents |
US5061802A (en) * | 1990-06-20 | 1991-10-29 | Merck & Co. Inc. | 17β-aminobenzoyl-4-aza-5α-androst-1-en-3-ones as benign prostatic hypertrophy agents |
IL101243A (en) * | 1991-03-20 | 1999-12-22 | Merck & Co Inc | Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history |
IL101245A0 (en) * | 1991-03-20 | 1992-11-15 | Merck & Co Inc | Pharmaceutical compositions for the treatment of prostatic cancer |
US5175155A (en) * | 1991-10-07 | 1992-12-29 | Sterling Winthrop Inc. | Win 49596-finasteride method of use and compositions |
WO1993023039A1 (en) * | 1992-05-20 | 1993-11-25 | Merck & Co., Inc. | Substituted 4-aza-5a-androstan-ones as 5a-reductase inhibitors |
US5710275A (en) * | 1992-05-20 | 1998-01-20 | Merck & Co., Inc. | 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors |
US5359071A (en) * | 1993-03-12 | 1994-10-25 | Merck & Co., Inc. | 15-substituted 4-azasteroids |
-
1994
- 1994-04-20 US US08/230,277 patent/US5525608A/en not_active Expired - Fee Related
-
1995
- 1995-04-17 CA CA002188034A patent/CA2188034A1/en not_active Abandoned
- 1995-04-17 AT AT95916443T patent/ATE198274T1/de not_active IP Right Cessation
- 1995-04-17 JP JP7527710A patent/JPH09512535A/ja active Pending
- 1995-04-17 WO PCT/US1995/004743 patent/WO1995028928A1/en active IP Right Grant
- 1995-04-17 AU AU22941/95A patent/AU684634B2/en not_active Ceased
- 1995-04-17 EP EP95916443A patent/EP0756481B1/de not_active Expired - Lifetime
- 1995-04-17 DE DE69519728T patent/DE69519728D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2294195A (en) | 1995-11-16 |
JPH09512535A (ja) | 1997-12-16 |
WO1995028928A1 (en) | 1995-11-02 |
EP0756481B1 (de) | 2000-12-27 |
AU684634B2 (en) | 1997-12-18 |
CA2188034A1 (en) | 1995-11-02 |
EP0756481A4 (de) | 1998-11-18 |
DE69519728D1 (de) | 2001-02-01 |
US5525608A (en) | 1996-06-11 |
EP0756481A1 (de) | 1997-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV12316A (lv) | 16-aizvietoti 4-azoandrostani ka 5-alfa-reduktazes izozima 1 inhibitori | |
ES2149208T3 (es) | Inhibidores 4-azaesteroides de 5-alfa-reductasa. | |
TW270922B (de) | ||
PT1203770E (pt) | Piran -2-onas e 5, 6-di-hidropiran-2-onas uteis para o tratamento de hiperplasia e outras doencas | |
DE69326008D1 (de) | 17-amino-substituierte 4-azasteroide als 5-alpha-reductase inhibitoren | |
ATE178795T1 (de) | 7-substituierte-4-aza-steroid-derivate als 5- alpha-reductase-hemmer | |
ATE198274T1 (de) | 17 beta-aryl-4-aza-steroidderivate | |
DE69615046T2 (de) | 17-alkyl-7-substituierte-4-aza-steroidderivate | |
BR9203266A (pt) | Composto,formulacao farmaceutica,processo para inibir 5alfa-reductase,processos para tratar hiperplasia benigna da prostata,seborreia e alopecia androgenica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |